ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GlaxoSmithKline launches full-on assault on Gilead with 2-drug HIV regimen data
July 25, 2018GlaxoSmithKline's quest to trounce three-drug HIV therapies with its own two-drug regimens just got a boost. In detailed data from two trials, a combination of Tivicay (dolutegravir) and Epivir (lamivudine) squashed viral loads just as well as standard tr
Pharma Sources Insight January 2025
